Aevice Health is a fast-growing medtech startup in Singapore. It designs and develops monitoring devices for respiratory-related diseases, the first of which is targeted at asthma. The monitor features notifications via smartphone, ensuring early medical intervention when a child is about to develop an asthma attack. This empowers doctors to diagnose asthma faster, and for patients to better manage their condition.
Aevice Health was grown out of research conducted at Nanyang Technological University, one of the leading technical institutions in the world, and is led by a team of passionate innovators, scientists, and clinicians.
Aevice Health became an IEEE N3XT® Star at Switch 2018. Read about it here.